The prognostic value of chemosensitivity, estimated by the modeled CA-125 KELIM, in ovarian cancer patients treated with neo-adjuvant chemotherapy in the Netherlands

被引：8
|
作者：
Van Wagensveld, L. [1 ]
Colomban, O. [2 ]
Van der Aa, M. [3 ]
Tod, M. [4 ]
Sonke, G. S. [5 ]
Kruitwagen, R. [6 ]
You, B. [7 ]
机构：
[1] IKNL Netherlands Comprehens Canc Org, Res, Utrecht, Netherlands
[2] Univ Claude Bernard Lyon 1, Fac Med & Maieut Lyon Sud Charles Merieux, Ciblage Therapeut Oncol, EMR3738, Oullins, France
[3] Netherlands Comprehens Canc Org IKNL, Res, Amsterdam, Netherlands
[4] Univ Claude Bernard Lyon 1, EMR UCBL HCL 3738, Lyon, France
[5] Netherlands Canc Inst, Antoni van Leeuwenhoek Hosp, Dept Med Oncol, Amsterdam, Netherlands
[6] Maastricht Univ, Med Ctr, Dept Obstet & Gynecol, Maastricht, Netherlands
[7] Univ Claude Bernard Lyon 1, Inst Cancerol Hosp Civils Lyon IC HCL, Fac Med Lyon Sud, Citohl,GINECO,1 Univ Lyon,EMR UCBL HCL 3738,Med O, Lyon, France
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.986
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
847P
引用
收藏
页码：S633 / S633
页数：1
相关论文
共 50 条
  • [1] Role of tumor primary chemosensitivity assessed by modeled CA-125 KELIM to predict complete interval debulking surgery (IDS) in ovarian carcinoma patients treated with neo-adjuvant chemotherapy and immunotherapy: A GINEGEPS/GINECO study of the NeoPembrOv and INeOV trials
    Corbaux, P.
    Leary, A.
    Le Saux, O.
    Colomban, O.
    Treilleux, I.
    Genestie, C.
    Chardin, L.
    Collet, L.
    Lefevre, L. Bengrine
    Kuentz, M. Auvray
    Martinez, M.
    Blonz, C.
    Priou, F.
    Alexandre, J.
    Cloarec, N.
    Lebreton, C.
    Venat, L.
    Savoye, A. M.
    You, B.
    Ray-Coquard, I. L.
    ANNALS OF ONCOLOGY, 2024, 35 : S583 - S583
  • [2] Strong relationships between the CA-125 KELIM score and the tumor biological effects after neo-adjuvant chemotherapy in advanced ovarian cancer patients: CHIVA trial (GINECO)
    Catana, A. M.
    Just, P-A.
    De Rauglaudre, G.
    Raban, N.
    Chevalier, A.
    Ferron, G.
    Kaminsky-Forrett, M-C.
    Ray-Coquard, I. L.
    Hamizi, S.
    Combe, P-F.
    Lacourtoisie, S. Abadie
    Lobbedez, F. Joly
    Meunier, J.
    Lebreton, C.
    Alexandre, J.
    Follana, P.
    Lotz, J-P.
    Del Piano, F.
    Colomban, O.
    You, B.
    ANNALS OF ONCOLOGY, 2023, 34 : S532 - S532
  • [3] Dynamic Prediction of Resectability for Patients with Advanced Ovarian Cancer Undergoing Neo-Adjuvant Chemotherapy: Application of Joint Model for Longitudinal CA-125 Levels
    Amroun, Koceila
    Chaltiel, Raphael
    Reyal, Fabien
    Kianmanesh, Reza
    Savoye, Aude-Marie
    Perrier, Marine
    Djerada, Zoubir
    Bouche, Olivier
    CANCERS, 2023, 15 (01)
  • [4] THE PROGNOSTIC VALUE OF POST CHEMOTHERAPY SERUM CA-125 IN EPITHELIAL OVARIAN-CANCER
    TEELING, M
    MCGING, P
    CARNEY, DN
    IRISH JOURNAL OF MEDICAL SCIENCE, 1989, 158 (03) : 59 - 62
  • [5] THROMBOEMBOLISM IN PATIENTS WITH ADVANCED OVARIAN CANCER ON NEO-ADJUVANT CHEMOTHERAPY
    Azam, F.
    Al-Selwi, W.
    Coventry, T.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 1279 - 1279
  • [6] The prognostic value of pretherapeutic tetranectin and CA-125 in patients with relapse of ovarian cancer
    Deng, XH
    Hogdall, EVS
    Hogdall, CK
    Norgaard-Pedersen, B
    Jorgensen, M
    Nielsen, H
    Engelholm, SAA
    GYNECOLOGIC ONCOLOGY, 2000, 79 (03) : 416 - 419
  • [7] PROGNOSTIC VALUE OF CA-125 IN ADVANCED OVARIAN-CANCER
    MOGENSEN, O
    GYNECOLOGIC ONCOLOGY, 1992, 44 (03) : 207 - 212
  • [8] Prognostic and predictive significance of CA-125 elimination rate constant K (KELIM) in ovarian cancer patients treated with neoadjuvant chemotherapy in a real-world setting.
    Liontos, Michael
    Papatheodoridi, Alkistis
    Kunadis, Elena
    Svarna, Anna
    Theofanakis, Charalampos
    Fiste, Oraianthi
    Rouvali, Angeliki
    Goula, Kalliroi
    Markellos, Christos
    Andrikopoulou, Angeliki
    Potiri, Eirini
    Papanota, Aristea-Maria
    Kaparelou, Maria
    Koutsoukos, Konstantinos
    Thomakos, Nikolaos
    Haidopoulos, Dimitrios
    Rodolakis, Alexandros
    Zagouri, Flora
    You, Benoit
    Dimopoulos, Meletios A.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [9] The Importance of the CA-125 Value in Patients with Ovarian cancer
    Bachmann, C.
    Bachmann, S.
    Grischke, E. M.
    Fehm, T.
    Wallwiener, D.
    Staebler, A.
    Solomayer, E. F.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2009, 69 (08) : 733 - 733
  • [10] PROGNOSTIC VALUE AND ASSOCIATION WITH VELIPARIB BENEFIT OF MODELED CA-125 ELIMINATION KINETICS (KELIM) IN PATIENTS WITH NEWLY DIAGNOSED OVARIAN CANCER: ANALYSIS FROM THE VELIA/GOG-3005 STUDY
    You, B.
    Fleming, G.
    Bookman, M.
    Moore, K. N.
    Steffensen, K. D.
    Coleman, R. L.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 : A24 - A25
12345